Risk factors for infection in haematology patients treated with rituximab.
Kanbayashi Y, Nomura K, Fujimoto Y, Yamashita M, Ohshiro M, Okamoto K, Matsumoto Y, Horiike S, Takagi T, Ishida Y, Taniwaki M; Japan Haematology/Oncology Study (J-HOST) Group.
Kanbayashi Y, et al.
Eur J Haematol. 2009 Jan;82(1):26-30. doi: 10.1111/j.1600-0609.2008.01165.x. Epub 2008 Nov 11.
Eur J Haematol. 2009.
PMID: 19018858